Replies to post #383014 on Innovation Pharmaceuticals Inc (IPIX)

[oddone33320]

Forgive my ignorance, but presumably the $2 million proceeds from the sale of the preferred shares goes to the company. What could they be needing an extra $2 mil for at this time? The B-IBD/UC drug reformulation? Settle liabilities?

[centillion]

The 10-Q is dated today 11/09/2021. Leo knows nothing of the trial data, yet!

The Phase 2 COVID-19 clinical trial data as of the date of this Form 10-Q remains blinded to the Company. The Company’s biostatistics vendor is currently engaged in analyzing and computing study data and they are expected to deliver Topline results to the Company during the second week of November, 2021.

[Lemoncat]

How often does Ehrlich file before the due date? That should be a clue.

Quite routinely actually. With the exception of 2020 and 2019 he has filed on 11/8 or 11/9 all the way back to 2012.

2021 11/9
2020 11/16
2019 11/13
2018 11/8
2017 11/8
2016 11/9
2015 11/9
2014 11/8
2013 11/8
2012 11/13

https://www.sec.gov/edgar/browse/?CIK=1355250

You should really know the answer to your questions before you ask them of others if you expect them to support your point rather than demolish it.

Go IPIX!

[bradfordbros]

Another misreport.

[attilathehunt]

"And why issue $2 million of preferred shares before the results are public?"

According to some of your previous posts, he may wanted to enrich his friends.

Who bought them may be a better question.